PHCbi launches -85℃ compact CFC-free ultra-low temperature freezer aiming to contribute to reducing environmental impact
Tuesday, September 05, 2023
PHC Corporation Biomedica Division (Headquarters: Minato-ku, Tokyo, President and Representative Director: Nobuo Nakamura, hereinafter referred to as “PHCbi”) has announced that it is a pharmaceutical company and research company. For facilities and medical institutions, -85℃ compact CFC-free ultra-low temperature freezer that pursues reducing the burden on the global environment and improving energy-saving performance (product number: MDF-DC102VH-PJ [84L]/DC202VH-PJ [180L]) (* 1 ) has been released, we would like to inform you.
The world is moving forward with the goal of becoming carbon neutral by 2050, aiming to realize the Paris Agreement adopted in 2015 to solve the problem of climate change. In addition to the urgent issue of reducing anthropogenic emissions of greenhouse gases, mainly carbon dioxide, coupled with the soaring global fuel prices, there is a need for a wide range of environmentally friendly products with high energy-saving performance. Masu.
The recently released "MDF-DC102VH-PJ/DC202VH-PJ" not only allows researchers involved in drug discovery and life science research to efficiently and safely store valuable biological samples and pharmaceuticals for long periods of time, but also uses CFC-free refrigerants. This is a -85°C compact non-Freon ultra-low temperature freezer that contributes to reducing the burden on the global environment by reducing power consumption. By using a highly energy-efficient natural refrigerant (*2) and installing a new high-output compressor that reduces the total amount of refrigerant charged, it achieves up to 41% energy savings ( *4) compared to the previous model (*3). ) has been realized. By reducing power consumption in research facilities and medical institutions, we contribute to reducing running costs and preventing global warming. By using natural refrigerants with low GWP values (global warming potential), we also help prevent ozone layer depletion. Contribute.
In addition, by expanding the controllable temperature range from -85°C to -60°C to -85°C to -40°C, a wider range of samples, such as biopharmaceuticals, can be stored frozen. In addition, since various operating data such as the temperature inside the refrigerator and alarm history can be transferred to a USB memory, it is useful for quality control of stored items.
Since PHCbi launched a medicinal refrigerator in Japan in 1966, we have been working on the development of a wide range of life science equipment centered on preservation and culture equipment. The purpose of this new product is to expand the lineup of CFC-free ultra-low temperature freezers, one of our main products, and to promote the realization of the PHC Group's medium-term management plan "Value Creation Plan (FY22-FY25)" (*5 ) . is.
Shinro Nakamura, President and CEO of PHC Corporation and General Manager of the Biomedical Business Division, said, "In 2018, we introduced a vertical CFC-free ultra-low-temperature freezer called 'VIP ECO ( *6) ”, and in 2022, the “VIP ECO SMART (*7) ”, which achieves even greater energy savings, will be launched, and its excellent energy-saving performance has been highly evaluated by customers around the world. Along with the growth of the market for biopharmaceuticals such as biopharmaceuticals, the demand for small ultra-low temperature freezers in clinical settings is expected to increase. Based on the PHC Group's sustainability initiatives (*8) , we hope to contribute to the realization of a decarbonized society by providing products with superior energy-saving performance.
(*1) URL:
www.phchd.com/jp/biomedical/preservation/ultra-low-freezers/mdf-dc102vh
www.phchd.com/jp/biomedical/preservation/ultra-low-freezers/mdf-dc202vh
(* 2) HC mixed refrigerant
(*3) Comparison with MDF-C8V
(*4) Comparison of power consumption per liter capacity (60Hz model)
(*5) Medium-term business plan for FY22-FY25 announced by PHC Holdings Corporation : www.phchd.com/jp/about/vcp
(*6) URL: www.phchd.com/jp/phc/news/2018/0718
(*7) URL: www.phchd.com/jp/phc/news /2022/1212
(*8) PHC Group Sustainability Site: www.phchd.com/jp/sustainability
About PHC Corporation Biomedica Division
Established in 1969, PHC Corporation is a Japanese operating subsidiary of PHC Holdings Corporation (code number 6523, TSE Prime), which operates as a global healthcare company. The Biomedica Division, which handles the life science business, has a business brand of "PHCbi" and works with scientists in approximately 110 countries and regions through the provision of research and medical support equipment and services, including ultra-low temperature freezers and CO 2 incubators. We are committed to supporting researchers.
www.phchd.com/jp/biomedical/about-phcbi
About PHC Holdings Co., Ltd.
PHC Holdings Corporation (Securities Code: 6523 TSE Prime) is a global healthcare company whose management philosophy is to create new value for all people who desire good health and contribute to the creation of a prosperous society. With subsidiaries such as PHC Corporation, Ascensia Diabetes Care Holdings, Epredia Holdings, LSI Medience Co., Ltd., and WeMex Co., Ltd., it develops, manufactures, and sells in the business areas of diabetes management, healthcare solutions, diagnostics and life sciences. , is servicing. Consolidated revenue for fiscal 2022 is 356.4 billion yen, and our products and services are used by customers in more than 125 countries and regions around the world. PHC Group is a collective term for PHC Holdings Corporation and its operating subsidiaries.
www.phchd.com/jp
Contacts
Inquiries
Masayo Okada,
Marketing Department, Biomedical Division, PHC Corporation Phone: 080-4816-3259 E-mail: masayo.okada@phchd.com
IR Press Contact
PHC Holdings Corporation IR & Public Relations Department
Hiroko Arai
Telephone: 03-6778-5311
E-mail: phc_pr@gg.phchd.com
Source: businesswire.com